Legal Opinion
Novartis Pharmaceuticals v. Accord Healthcare Inc.
Court of Appeals for the Federal Circuit
Decided January 3, 2022No. 21-1070PublishedCited by 7 opinions
1Opinion of the Court
Case: 21-1070 Document: 41 Page: 1 Filed: 01/03/2022 United States Court of Appeals for the Federal Circuit ______________________ NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellee v. ACCORD HEALTHCARE, INC., AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., DR. REDDY’S LABORATORIES, INC., DR. REDDY’S LABORATORIES, LTD., EMCURE PHARMACEUTICALS LTD., HERITAGE PHARMACEUTICALS INC., GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS LIMITED, HETERO USA, INC., HETERO LABS LIMITED UNIT-V, HETERO LABS LIMITED, MYLAN PHARMACEUTICALS, INC., PRINSTON PHARMACEUTICAL INC., STRIDES…
2Cases cited27 opinions
- Anderson v. City of Bessemer CitySupreme Court of the United States · 1985
- Graver Tank & Mfg. Co. v. Linde Air Products Co.Supreme Court of the United States · 1950
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
- Vas-Cath Incorporated and Gambro, Inc. v. Sakharam D. Mahurkar, and Quinton Instruments CompanyCourt of Appeals for the Federal Circuit · 1991
22 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- Almirall, LLC v. Amneal Pharmaceuticals LLCCourt of Appeals for the Federal Circuit · 2022
- Novartis Pharmaceuticals v. Accord Healthcare Inc.Court of Appeals for the Federal Circuit · 2022
- Biogen International Gmbh v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2022
- Almirall, LLC v. Amneal Pharmaceuticals LLCCourt of Appeals for the Federal Circuit · 2022
- Biogen International Gmbh v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2022
2 more not listed; retrieve them via the Exa API.